• Corpus ID: 44714207

Common questions about the diagnosis and management of benign prostatic hyperplasia.

@article{Pearson2014CommonQA,
  title={Common questions about the diagnosis and management of benign prostatic hyperplasia.},
  author={Ryan D Pearson and Pamela M. Williams},
  journal={American family physician},
  year={2014},
  volume={90 11},
  pages={
          769-74
        }
}
Benign prostatic hyperplasia (BPH) is a common condition that increases in prevalence with age. A history should include onset, duration, and severity of lower urinary tract symptoms and medication use to rule out other causes of symptoms. Physical examination includes a digital rectal examination and assessment for bladder distention or neurologic impairment. Recommended tests include serum prostate-specific antigen measurement and urinalysis to help identify infection, genitourinary cancer… 

Figures and Tables from this paper

Urinary Retention in Adults: Evaluation and Initial Management.
TLDR
Patients with urinary retention related to an underlying neurologic cause should be monitored in conjunction with neurology and urology subspecialists and diagnostic testing should include measurement of postvoid residual volume of urine.
Emerging techniques in ‘truly’ minimal-invasive treatment options of benign prostatic obstruction
TLDR
Recent results in different treatment options for benign prostate hypoplasia (BPH) are reported and others may be recognized in clinical practice as a suitable alternative treatment to transurethral resection of the prostate and medical therapy.
Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
  • S. Ooi, S. Pak
  • Medicine
    Journal of alternative and complementary medicine
  • 2017
TLDR
The totality of evidence includes favorable patients' response from clinical experience, impact of placebo effect, early positive studies, subjective nature of symptom reporting, pharmacological properties of S. repens, and potential synergistic effects when combined with other therapies.
Herbal medicine for benign prostatic hyperplasia
TLDR
The efficacy and safety of herbal medicine as a treatment for BPH is assessed using the Cochrane risk of bias assessment tool and confidence in the cumulative evidence is evaluated using the GRADE approach.
Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology
  • S. Allen, I. Aghajanyan
  • Medicine
    The aging male : the official journal of the International Society for the Study of the Aging Male
  • 2017
TLDR
It is demonstrated that TT is effective for BPH, suggesting that blood circulation plays a crucial role in its cause.
Moxibustion for Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
TLDR
This meta-analysis of clinical trials suggests that moxibustion is effective intreating BPH patients and could be applied to clinical treatment of BPH.
Complicaciones infecciosas después de prostatectomía abierta y resección transuretral de próstata en pacientes con hiperplasia prostática benigna
Benign prostatic hyperplasia (BPH) is the most common tumor in men and may require surgical treatment when there is urinary retention, obstructive uropathy, recurrent hematuria, cystolithiasis or
Portal Hypertension Secondary to Benign Prostatic Hyperplasia
Cite this article as: Küçükyangöz M, Söğütdelen E, Gücük S, Gücük A. Portal Hypertension Secondary to Benign Prostatic Hyperplasia. J Urol Surg, 2022;9(1):74-75. Correspondence: Mustafa Küçükyangöz
Moxibustion for Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
TLDR
This study evaluates the effectiveness and safety of moxibustion for benign prostatic hyperplasia (BPH) and uses the keywords "benign prostaticHyperplasia", "benIGN prostatichypertrophy", and "prostatichyperplasia" to describe the process.
...
1
2
...

References

SHOWING 1-10 OF 42 REFERENCES
Cernilton for benign prostatic hyperplasia.
TLDR
The available evidence suggests Cernilton is well tolerated and modestly improves overall urologic symptoms including nocturia, and additional randomized placebo and active-controlled trials are needed to evaluate the long-term clinical effectiveness and safety of Cern Milton.
Contribution of common medications to lower urinary tract symptoms in men.
TLDR
The cross-sectional association between current use of selected common medications and LUTS among men enrolled in the California Men's Health Study is assessed.
Finasteride for benign prostatic hyperplasia.
TLDR
Finasteride consistently improved urinary symptom scores more than placebo in trials of > 1 year duration, and significantly lowered the risk of BPH progression, and was less effective than either doxazos in or terazosin, but equally effective compared to tamsulosin.
Pygeum africanum for benign prostatic hyperplasia.
TLDR
Compared to men receiving placebo, Pygeum africanum provided a moderately large improvement in the combined outcome of urologic symptoms and flow measures as assessed by an effect size defined by the difference of the mean change for each outcome divided by the pooled standard deviation for each outcomes.
BPH: epidemiology and comorbidities.
  • K. McVary
  • Medicine
    The American journal of managed care
  • 2006
TLDR
Although effective treatments for LUTS/BPH are available, this condition often occurs in the context of common, age-related comorbidities such as cardiovascular disease, hypertension, and erectile dysfunction.
Beta-sitosterols for benign prostatic hyperplasia.
TLDR
The evidence suggests non-glucosidic B-sitosterols improve urinary symptoms and flow measures and their long term effectiveness, safety and ability to prevent BPH complications are not known.
...
1
2
3
4
5
...